Page last updated: 2024-11-12
okenone
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
okenone: from Allochromatium minutissimum; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 12313697 |
| CHEBI ID | 80417 |
| SCHEMBL ID | 980791 |
| MeSH ID | M0498719 |
Synonyms (8)
| Synonym |
|---|
| okenone |
| CHEBI:80417 |
| SCHEMBL980791 |
| 1'-methoxy-1',2'-dihydro-chi,psi-caroten-4'-one |
| Q27149458 |
| all-trans okenone |
| QSE , |
| (6e,8e,10e,12e,14e,16e,18e,20e,22e,24e)-2-methoxy-2,6,10,14,19,23-hexamethyl-25-(2,3,4-trimethylphenyl)pentacosa-6,8,10,12,14,16,18,20,22,24-decaen-5-one |
Research Excerpts
Overview
Okenone is a unique ketocarotenoid found in many purple sulfur bacteria. It is important because of its unique light absorption and photoprotection properties. Okenone (from PSB) is abundant in both the chemocline waters and in benthic mats.
| Excerpt | Reference | Relevance |
|---|---|---|
| "Okenone is a carotenoid pigment unique to certain members of Chromatiaceae, the dominant family of purple sulfur bacteria (PSB) found in euxinic photic zones. " | ( Pigment production and isotopic fractionations in continuous culture: okenone producing purple sulfur bacteria Part II. Fogel, ML; Smith, DA; Steele, A, 2015) | 2.09 |
| "Okenone (from PSB) is an abundant carotenoid in both the chemocline waters and in benthic mats." | ( Carotenoid biomarkers as an imperfect reflection of the anoxygenic phototrophic community in meromictic Fayetteville Green Lake. Freeman, KH; Fulton, JM; Kump, LR; Macalady, JL; Meyer, KM; Schaperdoth, I, 2011) | 1.09 |
| "Okenone is a unique ketocarotenoid found in many purple sulfur bacteria; it is important because of its unique light absorption and photoprotection properties. " | ( Elucidation of the biosynthetic pathway for Okenone in Thiodictyon sp. CAD16 leads to the discovery of two novel carotene ketolases. Bryant, DA; Vogl, K, 2011) | 2.07 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Drug Classes (2)
| Class | Description |
|---|---|
| triterpenoid | Any terpenoid derived from a triterpene. The term includes compounds in which the C30 skeleton of the parent triterpene has been rearranged or modified by the removal of one or more skeletal atoms (generally methyl groups). |
| carotenoid chi-end group | |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
Pathways (1)
| Pathway | Proteins | Compounds |
|---|---|---|
| okenone biosynthesis | 5 | 11 |
Research
Studies (9)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 21.63
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (21.63) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 10 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||